Weekly Rounds with Infection Control Today: Mu Antibody Resistance, Drugs to Fight Candida Auris, Quarantined Workers
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending September 17.
Here are 5 highlights from ICT®’s wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders, to the news that infection preventionists and other health care professionals can use on their jobs.
More Data Point to COVID-19 Mu Variant’s Antibody Resistance
Researchers found the mu variant to be the most resistant variant to antibodies from either previous infection or from vaccines, a spot that had been previously occupied by the beta, or the South African, variant.
Drugs in Development Might Help Fight Deadly Candida Auris
New antifungal agents that are being investigated for possible use against C. auris, such as Ibrexafungerp (Brexafemme), show promise—so far.
Should Vaccinated Health Care Workers Reinfected with COVID-19 be Quarantined?
Vaccines work. They ward off severe illness and death. But they do not make health care workers invulnerable to breakthrough infections, according to a research letter in JAMA Open Network.
Improved Cleaning Needed to Fight Off Acinetobacter Baumannii
The pathogen can lurk on blankets, bed rails, trolley handles, sheets, door handles, light switches, bedside tables, bedside table drawers, curtains, sinks, food tables, curtains, normal saline stands.
Method That Repels Pathogens from Hospital Surfaces Studied
Investigators used acetone-washed, pre-autoclaved stainless-steel coupons coated with reformulated quaternary ammonium polymer to keep deadly pathogens at bay.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
